Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

with Sanofi pledging a $35 cap last year. The insulin manufacturers and the PBMs have blamed each other for the increase in prices, and lawmakers have called for greater transparency in the system ...

I'm a 65 year old with 52 years of diabetes type ... the Federal Trade Commission lawsuit against them for inflating insulin prices to boost their profits at the expense of vulnerable patients.

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps.

The Democrats' days in control of federal healthcare policy are numbered. But they were able to do quite a bit of damage ...

Ever since Russia invaded Ukraine in February 2022 and oil prices soared around the globe, the oil industry has enjoyed three highly lucrative years with historic profits. The sector is still ...

President Joe Biden achieved a lot of his goals, but his failure to expand the social safety net might have mattered more in ...